HIF1A and neoplasm: Simultaneously, ROS activate redox-sensitive survival pathways, such as NF-κB, HIF-1α, and Nrf2, through spatiotemporal dynamic fluctuations to remodel the TME to enhance the release of inflammatory cytokines, thus supporting the survival and proliferation of tumor cells [25,29,75,116,117].